Références bibliographiques
43
Del Papa, M. F., Hancock et al . (2007). Full activation of Enterococcus faecalis gelatinase by a Cterminal proteolytic cleavage. Journal of bacteriology, P.P 8835,8843.
Denes, É., & Hidri, N. (2009). Synergie et antagonisme en antibiothérapie. Antibiotiques, 11(2),
106,115.
Denis, F., Ploy, M et al. (2016). Bactériologie médicale: techniques usuelles. Elsevier Health Sciences.
Doublet, B., Bousquet-Mélou, A., Madec, J. Y. (2012). Le concept «One Health» en antibiorésistance
et les flux de gènes. Innovations agronomiques,
Eaton, T. J., Gasson, M. J. (2001). Molecular screening of Enterococcus virulence determinants and
potential for genetic exchange between food and medical isolates. Applied and environmental
microbiology, .
Euzéby, J. P. (1997). List of Bacterial Names with Standing in Nomenclature: a folder available on the
Internet. International Journal of Systematic and Evolutionary Microbiology, .
Ferrero, L., Cameron, B., (1994). Cloning and primary structure of Staphylococcus aureus DNA
topoisomerase IV: a primary target of fluoroquinolones. Molecular Microbiology, P.P 641,653.
Francois-Ngo, S., Mainardi, J. L. (1998). Enterococcus faecalis: aspects bacteriologique,
epidemiologique et therapeutique. Feuillets de biologie, P.P 21,26.
García-Solache, M., Rice, L. B. (2019). The Enterococcus: a model of adaptability to its
environment. Clinical microbiology reviews, P.P 10,1128.
GASMI, K., SAHRAOUI, H. Antibiorésistance des souches bactériennes impliquées dans les
infections du pied diabétique.
Hammami, F., Koubaa, M et al . (2020). Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A
Rare Adverse Effect. Journal of Pharmaceutical Care, P.P 90,92.
Haslay, C., & Leclerc, H. (1993). Microbiologie des eaux d'alimentation. Technique &
Documentation.
Huycke, M. M., Spiegel, C. A (1991). Bacteremia caused by hemolytic, high-level gentamicin-resistant
Enterococcus faecalis. Antimicrobial agents and chemotherapy, P.P 1626,1634.
Huycke, M. M., Spiegel, C. A., & Gilmore, M. S. (1991). Bacteremia caused by hemolytic, high-level
gentamicin-resistant Enterococcus faecalis. Antimicrobial agents and chemotherapy, 35(8), 1626,1634.
Isnard, C. (2017). Enterococcus spp.: entre pathogènes opportunistes et probiotiques (Doctoral
dissertation, Normandie Université).
43
Del Papa, M. F., Hancock et al . (2007). Full activation of Enterococcus faecalis gelatinase by a Cterminal proteolytic cleavage. Journal of bacteriology, P.P 8835,8843.
Denes, É., & Hidri, N. (2009). Synergie et antagonisme en antibiothérapie. Antibiotiques, 11(2),
106,115.
Denis, F., Ploy, M et al. (2016). Bactériologie médicale: techniques usuelles. Elsevier Health Sciences.
Doublet, B., Bousquet-Mélou, A., Madec, J. Y. (2012). Le concept «One Health» en antibiorésistance
et les flux de gènes. Innovations agronomiques,
Eaton, T. J., Gasson, M. J. (2001). Molecular screening of Enterococcus virulence determinants and
potential for genetic exchange between food and medical isolates. Applied and environmental
microbiology, .
Euzéby, J. P. (1997). List of Bacterial Names with Standing in Nomenclature: a folder available on the
Internet. International Journal of Systematic and Evolutionary Microbiology, .
Ferrero, L., Cameron, B., (1994). Cloning and primary structure of Staphylococcus aureus DNA
topoisomerase IV: a primary target of fluoroquinolones. Molecular Microbiology, P.P 641,653.
Francois-Ngo, S., Mainardi, J. L. (1998). Enterococcus faecalis: aspects bacteriologique,
epidemiologique et therapeutique. Feuillets de biologie, P.P 21,26.
García-Solache, M., Rice, L. B. (2019). The Enterococcus: a model of adaptability to its
environment. Clinical microbiology reviews, P.P 10,1128.
GASMI, K., SAHRAOUI, H. Antibiorésistance des souches bactériennes impliquées dans les
infections du pied diabétique.
Hammami, F., Koubaa, M et al . (2020). Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A
Rare Adverse Effect. Journal of Pharmaceutical Care, P.P 90,92.
Haslay, C., & Leclerc, H. (1993). Microbiologie des eaux d'alimentation. Technique &
Documentation.
Huycke, M. M., Spiegel, C. A (1991). Bacteremia caused by hemolytic, high-level gentamicin-resistant
Enterococcus faecalis. Antimicrobial agents and chemotherapy, P.P 1626,1634.
Huycke, M. M., Spiegel, C. A., & Gilmore, M. S. (1991). Bacteremia caused by hemolytic, high-level
gentamicin-resistant Enterococcus faecalis. Antimicrobial agents and chemotherapy, 35(8), 1626,1634.
Isnard, C. (2017). Enterococcus spp.: entre pathogènes opportunistes et probiotiques (Doctoral
dissertation, Normandie Université).